What supplements are being studied for cancer treatment?

Research is ongoing for berberine, curcumin, resveratrol, quercetin, fisetin, apigenin, vitamin D, omega-3 fatty acids, green tea extract (EGCG), and many other natural compounds. Your Cancer Breakthroughs aggregates the latest peer-reviewed studies on these supplements from PubMed and medical journals.

What are off-label cancer medications?

Off-label medications are drugs approved for other conditions being studied for cancer treatment, including metformin (diabetes medication), ivermectin (antiparasitic), fenbendazole and mebendazole (veterinary and human dewormers), and statins. These repurposed drugs are being investigated in clinical trials and research studies.

Where does Your Cancer Breakthroughs get its research data?

All articles are sourced from peer-reviewed medical databases including PubMed/NCBI, ClinicalTrials.gov, and major oncology journals like Nature Cancer, JAMA Oncology, The Lancet Oncology, and Journal of Clinical Oncology. The site is updated daily with new research.

What cancer biomarkers does Your Cancer Breakthroughs cover?

The site covers over 70 genetic markers and biomarkers including TP53, KRAS, BRAF, EGFR, HER2, BRCA1/2, PD-L1, ALK, ROS1, NTRK, and many others. It also covers liquid biopsies, ctDNA testing, and emerging diagnostic technologies.

Is Your Cancer Breakthroughs affiliated with any pharmaceutical company?

No. Your Cancer Breakthroughs is an independent research aggregator with no pharmaceutical affiliations. It collects, indexes, and archives scientific literature published by other organizations without editorial bias toward any particular treatment approach.

🎯 Your Cancer Breakthroughs

Your Home for "More Than Standard of Care" Cancer Research
Updated Daily

ℹ️ What We Cover (click to expand)

💊 Supplements & Nutraceuticals: Berberine, Curcumin, Resveratrol, Quercetin, Fisetin, Apigenin, CBD, Vitamins, and many more natural compounds

🔄 Off-Label Medications: Metformin, Ivermectin, Fenbendazole, Mebendazole, and other repurposed drugs being studied for cancer

🧬 Biomarkers & Diagnostics: 70+ genetic markers such as TP53, KRAS, BRAF, EGFR, HER2, BRCA1/2, PD-L1, liquid biopsies, and genetic testing

🔬 Clinical Trials: Phase I, II, and III studies, recruiting trials, and emerging treatment protocols

Filter by Cancer Type:

Search by Keyword: